Saturday 17 October 2026
Export CLPT’s income statement to Excel — free account
ClearPoint Neuro, Inc.
CLPT Healthcare Medical Devices
ClearPoint Neuro, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $37.0 million, up 17.8% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS fell 81.0%, free cash flow fell 173.5% and total debt rose 74.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
9.07
0.57
−5.91%
Follow CLPT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 4 | 2 |
| (103.13%) | (95.64%) | (149.72%) | (226.52%) | ||
| (46.03%) | (37.30%) | (47.08%) | (46.21%) | ||
ROIC |
(207.44%) | (48.45%) | (50.31%) | (61.31%) | |
Return on Tangible Assets |
(50.98%) | (46.05%) | (60.16%) | (83.08%) | |
Average Days of Receivables |
42.53 | 64.66 | 77.85 | 72.48 | |
Free Cash Flow per Share |
(0.49) | (0.86) | (0.90) | (1.04) | |
Free Cash Flow |
(13.82) | (24.45) | (26.70) | (31.29) | |
Capital Expenditures |
(0.74) | (0.52) | (0.98) | (1.11) | |
| Other line items | |||||
Cash ROIC |
(16.60%) | (19.87%) | (25.66%) | (34.62%) | |
Accounts Receivable Turnover |
8.72 | 6.57 | 6.60 | 6.68 | |
Accounts Payable Turnover |
15.83 | 11.00 | 8.63 | 8.58 | |
Inventory Turnover |
1.95 | 1.88 | 2.02 | 2.09 | |
Average Days of Payables |
19.87 | 32.11 | 55.59 | 49.71 | |
Days of Inventory on Hand |
180.91 | 213.67 | 204.55 | 203.48 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
40.75% | 37.59% | 37.03% | 37.47% | |
Selling, General and Administrative Expense of Revenue |
86.84% | 89.15% | 90.50% | 98.56% | |
Share Based Compensation of Revenue |
23.02% | 22.13% | 20.90% | 20.09% | |
Interest Coverage |
— | (9.41) | (6.84) | (5.99) | |
Operating CF/Net income |
0.57 | 0.94 | 0.88 | 0.87 | |
Depreciation/Fixed assets |
0.91 | 0.89 | 1.08 | 1.31 | |
Capex/Depreciation |
(0.38) | (0.22) | (0.31) | (0.28) | |
Revenue per Share |
1.21 | 1.31 | 1.37 | 1.40 | |
Operating CF per Share |
(0.46) | (0.84) | (0.87) | (1.00) | |
Capex per Share |
(0.03) | (0.02) | (0.03) | (0.04) | |
Capex to Sales |
0.02 | 0.01 | 0.02 | 0.03 |
Columns are period end dates